Renalytix Share Discussion Threads

[cambridgedon] 10/3/2021 15:41

Kantaro Biosciences Named to Fast Company's Annual List of the World's Most Innovative Companies for 2021 and Ranked First in the Joint Ventures Category.
Just seen this on FT site. Can't do any harm!
CD

[wan] 10/3/2021 15:39

More good news today -

Kantaro Biosciences Named to Fast Company's Annual List of the World's Most Innovative Companies for 2021 and Ranked First in...
10/03/2021 3:31pm
PR Newswire (US)

NEW YORK, March 10, 2021 /PRNewswire/ -- Kantaro Biosciences, LLC, a joint venture between the Mount Sinai Health System and RenalytixAI (LSE: RENX / NASDAQ: RNLX), announced today it has been named to Fast Company's prestigious annual list of the World's Most Innovative Companies for 2021 and ranked first in the Joint Ventures category. Kantaro launched in May 2020 in response to the COVID-19 pandemic to make a high-performing SARS-CoV-2 IgG antibody test created at Mount Sinai broadly accessible worldwide.

"We are honored to be named one of the World's Most Innovative Companies by Fast Company and recognized for our work to ensure Kantaro antibody test kits are widely available to aid in the global battle against COVID-19," said Sara Barrington, chief commercial officer at Kantaro.

Full release -

[mginvestor] 10/3/2021 14:27

Renalytix just tweeted this out.

I'll be listening to this in the evening.

I'm sure it will be worth it.

[toffeeman] 09/3/2021 18:23

The UK listing will be maintained because most of the last raise, was EIS funds and so need a UK AIM listing.

So we ar the big 10 - will it hold?

[hpcg] 09/3/2021 18:20

US is driving it because in all but name its a US company. I doubt the UK listing will be maintained in the fullness of time but I could be wrong. Not that it matters.

[wan] 09/3/2021 16:11

State side perhaps better appreciate the impending rapid growth (with FDA Approval) and the TAM in the US. Europe of course is offering another large growth opportunity in the fullness of time, as will expanded indications.

[mr roper] 09/3/2021 14:49

Yup, US fully driving this.

[mr roper] 08/3/2021 19:20

Double normal daily vol Stateside. Good to see a move on vol but I’d like to see some news drop as well.

[mr roper] 08/3/2021 15:41

Very good volume as well. News incoming?

[faz] 08/3/2021 14:59

gone vertical in the US again. Good to see there's buyers on any weakness

[mr roper] 08/3/2021 08:34

Short write up on Renx
hxxps://incomeinvestorweb.co.uk/2021/01/24/3-uk-listed-ai-shares/amp/?__twitter_impression=true

[sirshagalot] 05/3/2021 16:40

motley fool portfolio the name says it all.

[hpcg] 04/3/2021 21:08

Thanks Nimbo, always nice to know what the triggers are. Similarly, and by definition, we should welcome any and every new investor onboard.

[nimbo1] 04/3/2021 20:33

The spike was because it was added to a motley fool portfolio

[hpcg] 04/3/2021 18:52

Catching some heat from the Cathie The Clown show in the US, where lots of small biotech getting pummelled. I know this isn't us but we travel in those waters. Down 10% which is par for the course today.

[busterdog2] 04/3/2021 16:41

You never know....

[toffeeman] 04/3/2021 15:12

>> Post 822

[wan] 04/3/2021 08:08

Catching the eye in terms of the track record to date, and thus there is a good degree of certainly regarding hitting a number of near term milestones!

[mr roper] 04/3/2021 07:42

Well done on the spread bet move, hpcg.

The volume Stateside yesterday was pretty impressive. 4.5 x the usual daily volume.
Definitely starting to get some interest.

[hpcg] 03/3/2021 23:08

I did suggest a Nasdaq chart in the header :). Fortunately I moved my spread bets over to the US listing, which let's be honest is the leader, so I saw the move develop and added some more. Also can't be emphasised what a weak session it was for high PSR and tech stocks otherwise.

[mr roper] 03/3/2021 19:08

Fda approval would see it double in a couple of weeks I reckon. Maybe less.

[spittingbarrel] 03/3/2021 19:03

FDA approval would certainly do the trick.

[mr roper] 03/3/2021 19:00

Spotted a few tweets. JPM saying rev due in this quarter. Not sure if that’s enough to fly it 20%, maybe a leak re fda approval but would be surprised